- Home
- Others
- Resources and Statistics
- Approved Providers of Pre-Implantation Genetic Testing for Monogenic / Single Gene Defects and Chromosomal Structural Rearrangement Services
Resources
Approved Providers of Pre-Implantation Genetic Testing for Monogenic / Single Gene Defects and Chromosomal Structural Rearrangement Services
10 October 2024
Approved Providers of Pre-Implantation Genetic Testing for Monogenic/Single Gene Defects and Chromosomal Structural Rearrangement Services
Following the recent announcement by the Ministry of Health (MOH) on 4 May 2021 on the introduction of pre-implantation genetic testing for monogenic / single gene defects (PGT-M) and pre-implantation genetic testing for chromosomal structural rearrangements (PGT-SR) as regulated clinical services, the list of approved hospitals and medical clinics offering Assisted Reproduction (AR) service that patients can approach for PGT-M/SR services can be found below in Table 1. The list of approved providers is subject to change, and couples who require PGT-M or PGT-SR services are encouraged to confirm directly with their AR providers on their licensing status, should they have any queries.
Table 1: List of approved PGT-M/SR providers
Name of Provider | Address |
AR Centres | |
Alpha IVF Centre Alpha Women’s Specialists | 101 Irrawaddy Road, #12-07 to 14, Royal Square At Novena, S(329565) |
KK Women's and Children's Hospital | 100 Bukit Timah Road, S(229899) |
Monash IVF Fertility Centre | 101 Irrawaddy Road #08-01 Royal Square Medical Centre S(329565) |
Mount Elizabeth @ Heeren | 260 Orchard Rd The Heeren #05-01, 238855 |
Mount Elizabeth Hospital | 3 Mount Elizabeth, S(228510) |
National University Hospital | 5 Lower Kent Ridge Road S(119074) |
O&G Partners IVF Centre | 6A Napier Road, Gleneagles Hospital, #05-34, S(258500) |
Sincere IVF Center | 8 Sinaran Drive, Novena Specialist Center, #06-09/10/11, S(307470) |
Singapore General Hospital | Outram Road, S(169608) |
Thomson Fertility Centre | 290 Orchard Road, Paragon Medical Centre, #19-01, S(238859) |
Virtus Fertility Centre | 9 Scotts Road, Pacific Plaza, #09-01 to #09-05, S(228210) |
Laboratory | |
National University Hospital | 5 Lower Kent Ridge Road, S(119074) |
Updated as of 10 Oct 2024
Allowable Conditions for PGT-M/SR to be Performed
As part of the Regulatory Terms and Conditions, AR centres approved to provide PGT-M/SR services can only carry out PGT-M/SR for specified hereditary conditions listed below. MOH's approval must be sought for PGT-M/SR to be performed for conditions beyond the list provided.
Pre-implantation Genetic Testing for Monogenic / Single Gene Defects (PGT-M)
PGT-M using Polymerase Chain Reaction (PCR)-based single cell tests for the following genetic diseases:
Table 2: List of allowable conditions for PGT-M to be performed
Condition Type | Conditions |
|---|---|
(I) Autosomal Dominant Conditions | 1. Autosomal Dominant Dilated Cardiomyopathy (TTN) 2. Autosomal Dominant Retinitis Pigmentosa (PRPF3) 3. Breast-ovarian cancer, familial, susceptibility to, 1 (BRCA1) 4. Breast-ovarian cancer, familial, susceptibility to, 2 (BRCA2) 5. Facioscapulohumeral muscular dystrophy 1 (FSHD1) 6. Familial adenomatous polyposis 1 (APC) 7. Hereditary Pancreatitis (PRSS1-related highly penetrant pathogenic variants only i.e. p.Asn29Ile and p.Arg122His) 8. Huntington disease (HTT) 9. INS-related permanent neonatal diabetes 10. Li-Fraumeni syndrome (TP53) 11. Lynch syndrome 2 (MLH1) 12. Maple Syrup Urine Disease (MSUD) 13. Marfan syndrome (FBN1) 14. Multiple endocrine neoplasia, type 1 (MEN1) 15. Multiple endocrine neoplasia, type 2A (RET) 16. Myotonic dystrophy, type 1 (DMPK) 17. Osteogenesis imperfecta, type V (IFITM5) 18. PALB2-cancer predisposition syndrome (PALB2) 19. Plakophilin-2 (PKP2) (to exclude embryos affected with 2 pathogenic PKP2 gene variants) 20. Polycystic kidney disease 1 (PKD1) 21. Polycystic kidney disease 2 (PKD2) 22. Rhabdoid tumor predisposition syndrome 1 (SMARCB1) 23. Spinocerebellar ataxia, type 2 (ATXN2) 24. Spinocerebellar ataxia, type 3 (ATXN3) 25. STAT3 Hyper IgE Syndrome (STAT3-HIES) 26. Tuberous sclerosis 2 (TSC2) 27. Von Hippel-Lindau Syndrome (VHL) |
(II) Autosomal Recessive Conditions | 28. Adrenal hyperplasia, congenital, 1 (CYP21A2) 29. Alkuraya-Kucinskas syndrome (KIAA1109) 30. Alpha-thalassemia (HBA2 and HBA1 , but excluding deletional HbH disease and all other milder forms, such as alpha-thalassemia silent carrier or alpha-thalassemia carrier) 31. Autosomal Recessive Alport Syndrome (ARAS) (COL4A4) 32. Autosomal Recessive Congenital Titinopathy (TTN) 33. Autosomal Recessive Polymicrogyria (ADGRG1) 34. Beta-thalassemia (HBB) 35. Bile acid synthesis defect, congenital, type 2 / delta(4),3-oxosteroid 5-beta-reductase deficiency (AKR1D1) – only for couples with gene mutation leading to null enzyme activity 36. Ceroid lipofuscinosis, neuronal, 1 (PPT1) 37. Developmental and Epileptic Encephalopathy 44 (DEE 44), UBA5 gene 38. Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (PLOD1) 39. Galactosemia 1 / classical galactosemia (GALT) 40. Gaucher disease, type 1 (GBA) 41. Glycogen storage disease II, classical infantile form / Pompe disease (GAA) 42. Harlequin ichthyosis (ABCA12) 43. Herlitz junctional epidermolysis bullosa (LAMB3) 44. Infantile osteopetrosis, autosomal recessive 1 (TCIRG1) 45. Leigh Syndrome (Infantile Subacute Necrotising Encephalopathy) due to mitochondrial complex IV deficiency (SURF1) 46. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (HADHA) 47. Matthew Wood syndrome / Microphthalmia, syndromic 9 (STRA6) 48. Meckel Syndrome, Type 6 / Joubert syndrome 9 (CC2D2A) 49. Netherton syndrome (SPINK5) 50. Pierson syndrome (LAMB2) 51. Pseudo-TORCH syndrome 1 (OCLN) 52. Renal Tubular Dysgenesis (REN) 53. Renal tubular dysgenesis (AGT-related) 54. Sensenbrenner syndrome / Cranioectodermal dysplasia 1 (IFT122) 55. Short-rib thoracic dysplasia 3 with or without polydactyly (DYNC2H1) 56. Sickle Cell Anaemia (HBB) 57. Spinal muscular atrophy, Type 1 and Type 2 (SMN1) 58. Sulfite oxidase deficiency, isolated (SUOX) 59. Wolcott-Rallison syndrome (EIF2AK3) |
(III) X-linked Conditions | 60. Agammaglobulinemia, X-linked 1 (BTK) 61. Coffin-Lowry syndrome (RPS6KA3) 62. Duchenne/Becker muscular dystrophy (DMD) 63. Fabry disease, classic form (GLA) 64. Fragile X syndrome (FMR1) 65. Hemophilia A (F8) 66. Hemophilia B (F9) 67. Hydrocephalus, X-linked / MASA syndrome (L1CAM) 68. Incontinentia pigmenti / Bloch-Sulzberger syndrome (IKBKG) 69. Kennedy’s disease (AR) (alleles with more than or equal to 38 CAG repeats only) 70. Lowe oculocerebrorenal syndrome (OCRL) 71. Ocular albinism (GPR143) 72. Severe combined immunodeficiency (IL2RG) 73. WAS-related disorder 74. X-linked hypophosphatemia (XLH) |
Pre-Implantation Genetic Testing for Chromosomal Structural Rearrangements (PGT-SR)
PGT-SR using PCR-based single cell tests or comprehensive 24-chromosome analysis test kits that perform only low-pass/low-coverage sequencing for the following structural rearrangements:
Table 3: List of allowable conditions for PGT-SR to be performed
Condition Type | Conditions |
|---|---|
(I) Robertsonian Translocations | 1. rob(13;14)(q10;q10) |
(II) Reciprocal Translocations | 6. t(1;3)(p34;p21) |
(III) Inversions | 64. inv(1)(p36.1q42.3) |
(IV) Miscellaneous | 71. mos del(11)(q14.2q23.2) |